Key Findings
The Europe DNA sequencing market is set to record a CAGR of 17.23% during the forecast period, 2021-2028. The increasing prioritization of DNA sequencing and the biotechnology industry due to technological innovations in the DNA sequencing platforms, cloud computing applications to store DNA sequencing data, data storage & management, etc., drives the market growth.

Market Insights
The United Kingdom, Italy, Russia, Poland, Belgium, France, Germany, and Rest of Europe are assessed for the Europe DNA sequencing market growth evaluation. In Germany, the growing prevalence of diseases has resulted in increased investments in the medical research and healthcare sectors. Biotechnology companies and pharmaceuticals are investing considerably in personalized medicine, which is majorly dependent on next-generation sequencing. Most academic institutions accommodate such facilities. Moreover, hospitals and healthcare facilities are projected to get more advanced technologies in the next few years.
In France, the rising healthcare expenditure and growing incidence of diseases propel market growth. Also, the R&D expenditure is expected to increase during the forecast period. The government initiatives further drive market growth. For instance, the French Plan for Genomic Medicine 2025, commissioned in 2015. In Russia, research centers like the Research Centre for Medical Genetics promote market growth. It is a federal non-profit academic research institution that leads in the medical genetics field. Whereas, in countries like Belgium, the increasing implementation of genomic research fuels market growth.

Competitive Insights
Some of the market’s prominent players include F. Hoffmann-La Roche, Bio-Rad Laboratories Inc, Danaher Corporation (Integrated DNA Technologies Inc), Asuragen Inc, Merck KGaA, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments